SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-042457
Filing Date
2017-08-11
Accepted
2017-08-11 16:06:26
Documents
45
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471746_10q.htm 10-Q 522061
2 EXHIBIT 31.1 v471746_ex31-1.htm EX-31.1 9801
3 EXHIBIT 31.2 v471746_ex31-2.htm EX-31.2 9735
4 EXHIBIT 32.1 v471746_ex32-1.htm EX-32.1 3744
5 EXHIBIT 32.2 v471746_ex32-2.htm EX-32.2 3587
  Complete submission text file 0001144204-17-042457.txt   2621367

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atxi-20170630.xml EX-101.INS 394367
7 XBRL TAXONOMY EXTENSION SCHEMA atxi-20170630.xsd EX-101.SCH 27255
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20170630_cal.xml EX-101.CAL 21481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20170630_def.xml EX-101.DEF 184900
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20170630_lab.xml EX-101.LAB 194025
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20170630_pre.xml EX-101.PRE 211305
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 171025051
SIC: 2834 Pharmaceutical Preparations